Bioequivalence of Bicalutamide New Formulation in Japan

NCT01416870 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ICI176,334-1
DRUG: Casodex 80 mg tablet

Sponsor

AstraZeneca